Synageva BioPharma (GEVA) Submits Regulatory Filing in Mexico for Kanuma as LAL Deficiency Treatment
Tweet Send to a Friend
Synageva BioPharma (NASDAQ: GEVA) announced the submission to the Comisión Federal para la Protección contra Riesgos Sanitarios ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE